<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Kahook Dual Blade: Ab Interno Trabeculectomy - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjWjU1@ZWI987IKpWVigAAABY","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy","wgTitle":"Kahook Dual Blade: Ab Interno Trabeculectomy","wgCurRevisionId":87677,"wgRevisionId":87677,"wgArticleId":6415,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy","wgRelevantArticleId":6415,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,
"wgRestrictionEdit":[],"wgRestrictionMove":[],"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr",
"pageVariantFallbacks":"en"},"srfFilteredConfig":null,"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init",
"ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Glaucoma is one of the leading causes of blindness worldwide.&amp;#91;1&amp;#93; All current therapies for glaucoma target intraocular pressure (IOP) lowering either through the use of oral or topical medications, laser or surgical therapy. The trabecular meshwork (TM), specifically the juxtacanalicular meshwork, has long been thought to be the site of greatest resistance to aqueous outflow.&amp;#91;2&amp;#93;&amp;#91;3&amp;#93;  Incision and/or removal of the trabecular meshwork, i.e. Trabeculectomy or Goniotomy, has been successfully used to lower IOP in congenital glaucoma for years and more recently has been shown to be advantageous in adult patients as well.&amp;#91;4&amp;#93;&#10;&amp;#91;5&amp;#93;&#10;&amp;#91;6&amp;#93;&amp;#91;7&amp;#93;&amp;#91;8&amp;#93;&amp;#91;9&amp;#93;&amp;#91;10&amp;#93;&amp;#91;11&amp;#93;&amp;#91;12&amp;#93;"/>
<meta name="date" content="2022-12-24"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Kahook Dual Blade: Ab Interno Trabeculectomy" href="/w/index.php?title=Special:ExportRDF/Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Kahook_Dual_Blade_Ab_Interno_Trabeculectomy rootpage-Kahook_Dual_Blade_Ab_Interno_Trabeculectomy layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Kahook+Dual+Blade%3A+Ab+Interno+Trabeculectomy" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Kahook+Dual+Blade%3A+Ab+Interno+Trabeculectomy" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzywdpl2"></button>
					<div class="collapse navbar-collapse hbpzywdpl2" id="hbpzywdpl2">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Kahook Dual Blade: Ab Interno Trabeculectomy</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Ccapitena" title="User:Ccapitena">Cara Capitena Young, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Leonard.K.Seibold" title="User:Leonard.K.Seibold">Leonard K. Seibold, MD</a>,&#160;<a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>,&#160;<a href="/User:Ccapitena" title="User:Ccapitena">Cara Capitena Young, MD</a>,&#160;<a href="/User:Zafar.Gill" title="User:Zafar.Gill">Zafar Gill, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Up to Date</b>
</div>
</div>&#160;by <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a> on December 25, 2022.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table></div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Introduction"><span class="tocnumber">1</span> <span class="toctext">Introduction</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Indications_and_Pre-operative_Considerations"><span class="tocnumber">2</span> <span class="toctext">Indications and Pre-operative Considerations</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Contraindications"><span class="tocnumber">3</span> <span class="toctext">Contraindications</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Surgical_Technique"><span class="tocnumber">4</span> <span class="toctext">Surgical Technique</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Post-operative_Course"><span class="tocnumber">5</span> <span class="toctext">Post-operative Course</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Complications"><span class="tocnumber">6</span> <span class="toctext">Complications</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Clinical_Outcomes"><span class="tocnumber">7</span> <span class="toctext">Clinical Outcomes</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Conclusions"><span class="tocnumber">8</span> <span class="toctext">Conclusions</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Introduction">Introduction</span></h1>
<p>Glaucoma is one of the leading causes of blindness worldwide.<sup id="cite_ref-tham1_1-0" class="reference"><a href="#cite_note-tham1-1">&#91;1&#93;</a></sup> All current therapies for glaucoma target intraocular pressure (IOP) lowering either through the use of oral or topical medications, laser or surgical therapy. The trabecular meshwork (TM), specifically the juxtacanalicular meshwork, has long been thought to be the site of greatest resistance to aqueous outflow.<sup id="cite_ref-grant2_2-0" class="reference"><a href="#cite_note-grant2-2">&#91;2&#93;</a></sup><sup id="cite_ref-tamm3_3-0" class="reference"><a href="#cite_note-tamm3-3">&#91;3&#93;</a></sup>  Incision and/or removal of the trabecular meshwork, i.e. Trabeculectomy or Goniotomy, has been successfully used to lower IOP in congenital glaucoma for years and more recently has been shown to be advantageous in adult patients as well.<sup id="cite_ref-chang4_4-0" class="reference"><a href="#cite_note-chang4-4">&#91;4&#93;</a></sup>
<sup id="cite_ref-sieck5_5-0" class="reference"><a href="#cite_note-sieck5-5">&#91;5&#93;</a></sup>
<sup id="cite_ref-mansouri6_6-0" class="reference"><a href="#cite_note-mansouri6-6">&#91;6&#93;</a></sup><sup id="cite_ref-abdullah7_7-0" class="reference"><a href="#cite_note-abdullah7-7">&#91;7&#93;</a></sup><sup id="cite_ref-greenwood8_8-0" class="reference"><a href="#cite_note-greenwood8-8">&#91;8&#93;</a></sup><sup id="cite_ref-francis9_9-0" class="reference"><a href="#cite_note-francis9-9">&#91;9&#93;</a></sup><sup id="cite_ref-mansouri10_10-0" class="reference"><a href="#cite_note-mansouri10-10">&#91;10&#93;</a></sup><sup id="cite_ref-dorairaj11_11-0" class="reference"><a href="#cite_note-dorairaj11-11">&#91;11&#93;</a></sup><sup id="cite_ref-radcliffe12_12-0" class="reference"><a href="#cite_note-radcliffe12-12">&#91;12&#93;</a></sup>
</p><p>The Kahook Dual Blade (KDB, New World Medical, Rancho Cucamonga, CA) is a novel goniotomy blade created to produce a more complete removal of TM through a minimally invasive approach. It was launched in the United States in 2015 and was designed to achieve near complete removal of TM with minimal, if any, surrounding tissue damage.  This is in contrast to other ab interno trabeculectomy techniques (Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) and traditional trabeculotomy), where the TM is incised and therefore residual TM leaflets remain post-procedure. In addition, the Trabectome (Neomedix Corporation, Tustin, CA) has been shown to both have residual leaflets and cause thermal injury to nearby tissues.<sup id="cite_ref-seibold13_13-0" class="reference"><a href="#cite_note-seibold13-13">&#91;13&#93;</a></sup> A pre-clinical study on human donor corneo-scleral rims demonstrated histologically the more complete TM removal with less surrounding tissue damage with the KDB compared to both Trabectome and an MVR blade trabeculotomy.<sup id="cite_ref-seibold13_13-1" class="reference"><a href="#cite_note-seibold13-13">&#91;13&#93;</a></sup><sup id="cite_ref-sooHoo14_14-0" class="reference"><a href="#cite_note-sooHoo14-14">&#91;14&#93;</a></sup> Minimizing residual trabecular meshwork leaflets theoretically may lead to less fibrosis overtime and therefore potentially enhance long term outcomes compared to other similar procedures. 
</p><p>The dual blade has several key design features to achieve a more complete goniotomy. First is the sharp tip designed with a taper to allow for smooth entry of the blade through TM and into Schelmm’s Canal (SC). The heel of the device fits easily within SC and allows smooth advancement of the blade within the canal while preventing collateral damage during treatment.  The ramp of the blade generates a gentle stretch of the TM as the blade is advanced. Finally, the dual blades create parallel incisions of the TM allowing excision of a strip of TM which achieves a near complete removal of TM, instead of incision only.<sup id="cite_ref-seibold13_13-2" class="reference"><a href="#cite_note-seibold13-13">&#91;13&#93;</a></sup><sup id="cite_ref-sooHoo14_14-1" class="reference"><a href="#cite_note-sooHoo14-14">&#91;14&#93;</a></sup>
</p><p>An additional benefit of the KDB, is that it is a single use, disposable instrument which does not require any additional special surgical equipment. Further, there is no implant related risks as no implant is left behind with this procedure. 
</p>
 <div class="center"><div class="thumb tnone"><div class="thumbinner" style="width:677px;"><a href="/File:KDB_blade_a.jpg" class="image"><img alt="KDB blade a.jpg" src="/w/images/1/0/01/KDB_blade_a.jpg" decoding="async" width="675" height="111" class="thumbimage" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:KDB_blade_a.jpg" class="internal" title="Enlarge"></a></div></div></div></div></div> 
<h1><span class="mw-headline" id="Indications_and_Pre-operative_Considerations">Indications and Pre-operative Considerations</span></h1>
<p>Goniotomy with the Kahook Dual Blade is indicated for the treatment of open angle glaucoma and ocular hypertension. Patients with uncontrolled IOP or those who have controlled IOP but other factors such as multiple drug allergies, drug intolerance, or non-compliance may be considered for this procedure.  It is approved as a standalone procedure or in combination with phacoemulsification (phaco) cataract surgery. When used as a standalone procedure it can be performed in pseudophakic or phakic patients. In phakic patients, special care should be taken to avoid damage to the lens capsule. While it is indicated with any disease severity it may be inappropriate for patients with a very low target IOP given that successful goniotomy still depends on patent aqueous outflow pathways downstream.  Therefore, it should not be expected to lower IOP beyond episcleral venous pressure (i.e. 8-10mmHg).<sup id="cite_ref-allingham15_15-0" class="reference"><a href="#cite_note-allingham15-15">&#91;15&#93;</a></sup> Patients with more distal scarring and outflow malfunction may also have limited success with these procedures. 
</p><p>Specific success has been seen in patients with secondary open angle glaucoma such as pseudoexfoliation glaucoma and pigmentary glaucoma.<sup id="cite_ref-sieck5_5-1" class="reference"><a href="#cite_note-sieck5-5">&#91;5&#93;</a></sup>  Since the mechanism of elevated IOP in these patients is related to accumulation of extracellular material and pigment within the TM respectively, it is intuitive that removal of the TM should improve IOP. The KDB goniotomy has also shown success in congenital glaucoma<sup id="cite_ref-khouri16_16-0" class="reference"><a href="#cite_note-khouri16-16">&#91;16&#93;</a></sup> and has been used in patients with uveitic and/or steroid induced glaucoma with reported success.  Prior success or failure of selective laser trabeculoplasty has not been shown to affect success rate with the KDB.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17">&#91;17&#93;</a></sup> 
</p><p>Other patient factors that should be considered are patient cooperation and quality of the gonioscopic view. Patients should ideally have a clear cornea, the ability to avoid eye movements for several minutes at a time and clearly identifiable angle structures. In order to produce adequate angle visualization, patients must be able to rotate their neck by approximately 30-45 degrees. While not a definite contraindication, special consideration should be given to anti-coagulated patients given the risk of hyphema.
</p>
<h1><span class="mw-headline" id="Contraindications">Contraindications</span></h1>
<p>KDB goniotomy is contraindicated in patients with active neovascularization, angle dysgenesis, and some forms of angle closure glaucoma. However, if peripheral anterior synechiae can be lysed to visualize the TM, KDB goniotomy may still be performed successfully. These cases usually require concomitant gentle goniosynechiolysis which can be performed either with the side of the dual blade or via the surgeon’s preferred technique. In cases of small PAS, these areas can be skipped and goniotomy can be performed only in the surrounding open areas. As noted above, patients with angle dysgenesis or non-identifiable angle structures are not ideal candidates for this procedure. Poor visualization of the angle, which may be due to corneal quality, lack of angle pigmentation or patient cooperation, is also a relative contraindication. 
</p>
<h1><span class="mw-headline" id="Surgical_Technique">Surgical Technique</span></h1>
<p>The Kahook Dual Blade goniotomy is most commonly performed under topical anesthesia. In children or less cooperative adults, it can be performed under general anesthesia. For patients that require general anesthesia, it is important to remind the anesthesia team that rotation of the patient’s head will be required before performing such maneuvers. Preoperative pilocarpine and/or intracameral miotic agents can be used in patients undergoing the procedure without phacoemulsification to facilitate visualization of the angle, but is not required. 
</p>
<div class="thumb tright"><div class="thumbinner" style="width:302px;"><a href="/File:KDB_blade_features.jpg" class="image"><img alt="KDB blade features.jpg" src="/w/images/1/thumb/f/ff/KDB_blade_features.jpg/300px-KDB_blade_features.jpg" decoding="async" width="300" height="125" class="thumbimage" srcset="/w/images/1/f/ff/KDB_blade_features.jpg 1.5x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:KDB_blade_features.jpg" class="internal" title="Enlarge"></a></div></div></div></div> 
<p>A corneal paracentesis is first created and the anterior chamber and angle are deepened with viscoelastic. Non-preserved lidocaine may be instilled intracamerally before viscoelastic for further anesthesia. A temporal clear corneal incision of at least 1.5mm is then created. More viscoelastic is added if necessary to deepen the nasal angle. Care should be taken not to over-inflate the eye as this can cause collapse of and difficulty entering the canal. Likewise, under inflation of the anterior chamber may result in corneal striae with gonioscopy. Next, the patient’s head is tilted approximately 30-45 degrees away from the surgeon and the microscope is tilted 45 degrees towards the surgeon. Viscoelastic is placed on the underside of a direct gonioprism and the device is inserted through the corneal incision sideways with the surgeon’s dominant hand while the gonioprism is placed on the ocular surface with the non-dominant hand so that the nasal TM is in direct view.  If anatomic structures are difficult to identify, Trypan blue can be used to stain the TM, or the IOP can be lowered temporarily to produce blood reflux into SC. The sharp tip of the blade is inserted through the TM and into SC. After the TM is pierced, the heel of the device is seated against the wall of SC and advanced in a clockwise or counterclockwise manner for approximately 3-5 clock hours depending on surgeon preference. As the device is advanced, the ramp gently stretches the TM while the dual blades create parallel incisions to generate a strip of TM.<sup id="cite_ref-seibold13_13-3" class="reference"><a href="#cite_note-seibold13-13">&#91;13&#93;</a></sup><sup id="cite_ref-sooHoo14_14-2" class="reference"><a href="#cite_note-sooHoo14-14">&#91;14&#93;</a></sup> If a large trabecular strip is present this  
</p>
<div class="thumb tleft"><div class="thumbinner" style="width:193px;"><a href="/File:Cleft_photo.jpg" class="image"><img alt="Cleft photo.jpg" src="/w/images/1/5/56/Cleft_photo.jpg" decoding="async" width="191" height="155" class="thumbimage" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Cleft_photo.jpg" class="internal" title="Enlarge"></a></div></div></div></div>
<p>can be removed with intraocular forceps. Small and/or peripheral strips however can be left in place. Viscoelastic is then irrigated from the anterior chamber and Carbachol intraocular solution may be injected intracamerally to produce pupillary miosis. All wounds are hydrated and checked to ensure water-tight closure and a 10-0 nylon is placed in the main wound if necessary. It is recommended that IOP be kept slightly high, around 20-25mmHg, at the end of the case to prevent further blood reflux, although this is patient and surgeon dependent. 
</p><p>When performed along with cataract surgery the goniotomy can be performed either before or after phacoemulsification at the surgeons’ preference as one study showed no difference in visualization as rated by surgeons whether the procedure was performed before or after phacoemulsification.<sup id="cite_ref-epstein17_18-0" class="reference"><a href="#cite_note-epstein17-18">&#91;18&#93;</a></sup>  When surveyed, 98% of surgeons agreed that the use of the blade was straightforward and 98-99% agreed the advancement of the blade within SC was efficient. <sup id="cite_ref-greenwood8_8-1" class="reference"><a href="#cite_note-greenwood8-8">&#91;8&#93;</a></sup><sup id="cite_ref-radcliffe12_12-1" class="reference"><a href="#cite_note-radcliffe12-12">&#91;12&#93;</a></sup>
</p>
<h1><span class="mw-headline" id="Post-operative_Course">Post-operative Course</span></h1>
<p>In cases where phacoemulsification is performed along with KDB goniotomy, antibiotic, NSAID and steroid drops are administered and tapered over one month post-operatively per surgeon preference. Pilocarpine 1% ophthalmic solution may also be used to maintain tension on the scleral spur and maintain patency of the TM cleft in the early post-operative period.  This is then tapered weekly over one month. A topical NSAID is not used in cases where phaco is not performed concomitantly. Pilocarpine should be avoided in high myopes or patients with a history of retinal detachment. Patients should be warned of the risk of blurred vision post-operatively either due to inflammation, blood reflux/hyphema, or refractive shifts with pilocarpine use. Patients are traditionally seen at post-operative day 1, week 1 and month 1, or sooner if complications occur. IOP spikes, if they occur, are treated if significant by re-starting ocular anti-hypertensives. In these cases, the topical steroid can be tapered faster or switched to a different formulation if a steroid response is suspected. 
</p><p>The use of ocular anti-hypertensives in the post-operative period varies by surgeon and by patient. Some surgeons prefer to stop all anti-hypertensives and only re-start if the IOP increases above goal. Others prefer to continue patients on their pre-operative medications or a modified pre-operative regimen and slowly taper drops off only after the patient is healed and finished with topical steroids. 
</p><p>In a retrospective cohort study of 70 eyes of 49 adult glaucoma patients, topical netarsudil was found to have greater IOP lowering efficacy in eyes treated with combined KDB goniotomy and cataract surgery compared to eyes that underwent cataract surgery alone.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19">&#91;19&#93;</a></sup> 
</p>
<h1><span class="mw-headline" id="Complications">Complications</span></h1>
<p>Most complications associated with KDB gonitomy are mild and self-limited.<sup id="cite_ref-mansouri10_10-1" class="reference"><a href="#cite_note-mansouri10-10">&#91;10&#93;</a></sup><sup id="cite_ref-dorairaj11_11-1" class="reference"><a href="#cite_note-dorairaj11-11">&#91;11&#93;</a></sup><sup id="cite_ref-radcliffe12_12-2" class="reference"><a href="#cite_note-radcliffe12-12">&#91;12&#93;</a></sup><sup id="cite_ref-seibold13_13-4" class="reference"><a href="#cite_note-seibold13-13">&#91;13&#93;</a></sup><sup id="cite_ref-sooHoo14_14-3" class="reference"><a href="#cite_note-sooHoo14-14">&#91;14&#93;</a></sup><sup id="cite_ref-allingham15_15-1" class="reference"><a href="#cite_note-allingham15-15">&#91;15&#93;</a></sup><sup id="cite_ref-khouri16_16-1" class="reference"><a href="#cite_note-khouri16-16">&#91;16&#93;</a></sup> The most commonly reported events are IOP spike and hyphema.  The rate of IOP spikes with phaco combined with KDB was approximately 6%<sup id="cite_ref-mansouri10_10-2" class="reference"><a href="#cite_note-mansouri10-10">&#91;10&#93;</a></sup><sup id="cite_ref-khouri16_16-2" class="reference"><a href="#cite_note-khouri16-16">&#91;16&#93;</a></sup> versus an approximate 12% rate in phaco combined with iStent (Glaukos Corporation, San Clemente, CA) according to one study. All IOP spikes resolved either spontaneously or with topical medications.<sup id="cite_ref-dorairaj11_11-2" class="reference"><a href="#cite_note-dorairaj11-11">&#91;11&#93;</a></sup> 
</p><p>Intraoperative hyphema is a common occurrence (approximately 40% incidence in most studies) due to blood reflux from SC. These are typically transient and have no effect on final IOP or best corrected visual acuity.<sup id="cite_ref-sieck5_5-2" class="reference"><a href="#cite_note-sieck5-5">&#91;5&#93;</a></sup><sup id="cite_ref-greenwood8_8-2" class="reference"><a href="#cite_note-greenwood8-8">&#91;8&#93;</a></sup> In a survey of surgeons, intraoperative blood reflux was seen in 39% of 120 eyes, with 9% of patients showing retained blood at post-operative day one and only 0.8% having residual hyphema after post-operative week one.<sup id="cite_ref-radcliffe12_12-3" class="reference"><a href="#cite_note-radcliffe12-12">&#91;12&#93;</a></sup> Other studies have noted a smaller incidence of hyphema post-operatively which may be due in part to inter-physician reporting variabilities. Regardless, this incidence is less frequent than quoted rates of hyphema with trabectome (100% intraoperative and 78% at post-operative day one) and GATT (30% at post-operative week one).<sup id="cite_ref-francis9_9-1" class="reference"><a href="#cite_note-francis9-9">&#91;9&#93;</a></sup><sup id="cite_ref-grover18_20-0" class="reference"><a href="#cite_note-grover18-20">&#91;20&#93;</a></sup> One study found a slight trend towards higher rates of hyphema in anti-coagulated patients but this was not statistically significant.<sup id="cite_ref-sieck5_5-3" class="reference"><a href="#cite_note-sieck5-5">&#91;5&#93;</a></sup> Hyphema requiring anterior chamber washout is rare.
</p><p>Other rare complications include corneal edema, rebound iritis, cyclodialysis cleft, posterior vitreous detachment and posterior capsular opacification, the incidences of which are 2%.<sup id="cite_ref-sieck5_5-4" class="reference"><a href="#cite_note-sieck5-5">&#91;5&#93;</a></sup><sup id="cite_ref-greenwood8_8-3" class="reference"><a href="#cite_note-greenwood8-8">&#91;8&#93;</a></sup><sup id="cite_ref-mansouri10_10-3" class="reference"><a href="#cite_note-mansouri10-10">&#91;10&#93;</a></sup><sup id="cite_ref-dorairaj11_11-3" class="reference"><a href="#cite_note-dorairaj11-11">&#91;11&#93;</a></sup><sup id="cite_ref-radcliffe12_12-4" class="reference"><a href="#cite_note-radcliffe12-12">&#91;12&#93;</a></sup> Descemet’s tears have been reported at a rate of 4%.<sup id="cite_ref-mansouri6_6-1" class="reference"><a href="#cite_note-mansouri6-6">&#91;6&#93;</a></sup> Careful entry and exit through the corneal wound with the blade held sideways can help to prevent these. There have been no cases of hypotony or endophthalmitis after KDB goniotomy in published studies.<sup id="cite_ref-sieck5_5-5" class="reference"><a href="#cite_note-sieck5-5">&#91;5&#93;</a></sup><sup id="cite_ref-mansouri6_6-2" class="reference"><a href="#cite_note-mansouri6-6">&#91;6&#93;</a></sup><sup id="cite_ref-abdullah7_7-1" class="reference"><a href="#cite_note-abdullah7-7">&#91;7&#93;</a></sup><sup id="cite_ref-greenwood8_8-4" class="reference"><a href="#cite_note-greenwood8-8">&#91;8&#93;</a></sup><sup id="cite_ref-francis9_9-2" class="reference"><a href="#cite_note-francis9-9">&#91;9&#93;</a></sup><sup id="cite_ref-mansouri10_10-4" class="reference"><a href="#cite_note-mansouri10-10">&#91;10&#93;</a></sup><sup id="cite_ref-dorairaj11_11-4" class="reference"><a href="#cite_note-dorairaj11-11">&#91;11&#93;</a></sup><sup id="cite_ref-radcliffe12_12-5" class="reference"><a href="#cite_note-radcliffe12-12">&#91;12&#93;</a></sup>
</p>
<h1><span class="mw-headline" id="Clinical_Outcomes">Clinical Outcomes</span></h1>
<p>Goniotomy with KDB continues to gain acceptance and widespread use amongst clinicians because of its favorable risk profile compared to both filtering surgeries and other MIGS procedures in addition to the documented success rates. Studies published since it came onto the market in 2015 have demonstrated these benefits. Given the relative novelty of this blade however, most published studies are limited to 1 year of follow up. 
</p><p>A prospective multicenter study by Dorairaj et al. of 52 eyes that underwent phaco in combination with KDB showed an IOP reduction of 26.2% at 1-year follow-up (P&lt;0.001). Pre-operative IOP average in this study was 16.8 ± 0.6 mmHg at baseline and 12.4 ± 0.3 mmHg at month 12. The same cohort had 63.5% of patients with at least 1 medication reduction at month 12.<sup id="cite_ref-mansouri10_10-5" class="reference"><a href="#cite_note-mansouri10-10">&#91;10&#93;</a></sup> In another multi-center study by Greenwood et al, 58.3% of patients had an IOP reduction of at least 20% and 61.7% were using at least 1 fewer IOP lowering medications after 6 months of follow up.<sup id="cite_ref-greenwood8_8-5" class="reference"><a href="#cite_note-greenwood8-8">&#91;8&#93;</a></sup>  A retrospective review of 100 patients who underwent goniotomy either with or without phaco in adults showed a significant decrease in IOP in all eyes (from 16.5 ± 5.0 mm Hg to 14.4 ± 3.7 in the combined group and 24.3 ± 9.1 mm Hg to 16.7 ± 7.6 in the standalone group) without a significant difference between the two groups at 18 months (P =0.5) .<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup> Another recent retrospective review of 197 eyes which underwent either KDB goniotomy alone or combined with phaco showed a significant decline in IOP and glaucoma medication usage at 1 year follow up. Success, defined as 20% decrease in IOP, was achieved in 71.8% of patients who underwent phaco-KDB and 68.8% of patients who underwent KDB goniotomy alone.<sup id="cite_ref-sieck5_5-6" class="reference"><a href="#cite_note-sieck5-5">&#91;5&#93;</a></sup> 
</p>
<div class="thumb tleft"><div class="thumbinner" style="width:449px;"><a href="https://eyewiki.org/File:IOP%20goniotomy%20istent%202.jpg"><img alt="IOP goniotomy istent 2.jpg" src="/w/images/1/0/01/IOP_goniotomy_istent_2.jpg" decoding="async" width="447" height="169" class="thumbimage" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:IOP_goniotomy_istent_2.jpg" class="internal" title="Enlarge"></a></div></div></div></div>
<p>Several studies have compared results of phaco plus KDB goniotomy to phaco plus iStent procedures. The KDB Goniotomy Study Group demonstrated that their phaco-KDB cohort experienced a significantly greater decrease in IOP (23.7% vs 16.4%, p&lt;0.001) and reduction in medication usage (1.1 vs 0.9 medications, p=0.001) when compared to the phaco-iStent group at 6 months follow up.<sup id="cite_ref-dorairaj11_11-5" class="reference"><a href="#cite_note-dorairaj11-11">&#91;11&#93;</a></sup> These results were further substantiated by a prospective randomized controlled trial by Falkenberry et al. comparing phaco-KDB and phaco-istent. At 12 months follow up, the primary outcome (20% or greater IOP reduction or medication reduction of 1 or more) was achieved by 74/79 patients (93.7%) in the phaco-KDB group and 65/78 patients (83.3%) in the phaco-iStent group (P =0.04).<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">&#91;22&#93;</a></sup> Finally, a large retrospective analysis of 315 eyes by ElMallah et al. demonstrated that mean IOP reductions were significantly greater in their phaco-KDB group than in their phaco-iStent group at all time points including month 12 [- 5.0 (0.3) mmHg vs. - 2.3 (0.4) mmHg, respectively, p &lt; 0.001].<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">&#91;23&#93;</a></sup>   
</p>
 <div class="thumb tright"><div class="thumbinner" style="width:460px;"><a href="/File:Meds_goniotomy_istent_2.jpg" class="image"><img alt="Meds goniotomy istent 2.jpg" src="/w/images/1/8/8e/Meds_goniotomy_istent_2.jpg" decoding="async" width="458" height="176" class="thumbimage" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Meds_goniotomy_istent_2.jpg" class="internal" title="Enlarge"></a></div></div></div></div><p>While the comparison between phaco plus KDB goniotomy and phaco plus iStent procedures has the most clinical data to date, there have been other studies comparing phaco plus KDB to other phaco-plus procedures. For example, Hirabayashi et al. compared phaco plus KDB to phaco plus 360° trabeculotomy (via either Trab360 or gonioscopy-assisted transluminal trabeculotomy [GATT]). They found that mean IOP reductions and medication reductions were similar between groups at 6 months. However, more eyes undergoing KDB than Trab360/GATT achieved target IOP ≤18 mmHg (80.0% [56/70] vs 59.3% [16/27], P=0.040) and ≤15 mmHg (61.4% [43/70] vs 25.9% [7/27], P=0.003).&#160;<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup>
</p><p>An important factor when considering any phaco plus procedure is its potential to impact refractive outcomes. Sieck et al. published a retrospective review of patients who received either phaco plus KDB or phaco alone and showed no significant difference in the rate of refractive surprise between the two groups. They found that refractive surprise greater than ±0.5 D occurred in 26.3% of eyes in the phaco-KDB group and 36.2% in the phacoemulsification group (p = 0.11). Refractive surprise greater than ±1.0 D occurred in 6.6% for the phaco-KDB group and 9.7% for the phacoemulsification group (p = 0.08). This data helps alleviate potential concerns regarding KDB’s impact on refractive outcomes when paired with cataract surgery.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup>
</p><p>In a subpopulation of individuals suffering from severe and/or refractory glaucoma and undergoing Kahook Blade Goniotomy in standalone fashion or in combination with phacoemulsification, mean IOP decreased from 18.1 + 5.0 mmHg at baseline to 14.8 + 3.7 mmHg at 12 months (18.2% reduction, P&lt;0.001)<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">&#91;26&#93;</a></sup>.
</p><p>Of note, all of the studies mentioned have included patients with mild, moderate, and severe glaucoma, however few, if any studies have evaluated whether success rates differed amongst these groups. Similarly, the majority of patients in these studies had primary open angle glaucoma, but cohorts also included patients with pigmentary, pseudoexfoliative, and angle closure glaucoma. Subgroup analyses were not routinely performed or were not of adequate power.<sup id="cite_ref-sieck5_5-7" class="reference"><a href="#cite_note-sieck5-5">&#91;5&#93;</a></sup><sup id="cite_ref-mansouri6_6-3" class="reference"><a href="#cite_note-mansouri6-6">&#91;6&#93;</a></sup><sup id="cite_ref-abdullah7_7-2" class="reference"><a href="#cite_note-abdullah7-7">&#91;7&#93;</a></sup><sup id="cite_ref-greenwood8_8-6" class="reference"><a href="#cite_note-greenwood8-8">&#91;8&#93;</a></sup><sup id="cite_ref-francis9_9-3" class="reference"><a href="#cite_note-francis9-9">&#91;9&#93;</a></sup><sup id="cite_ref-mansouri10_10-6" class="reference"><a href="#cite_note-mansouri10-10">&#91;10&#93;</a></sup><sup id="cite_ref-dorairaj11_11-6" class="reference"><a href="#cite_note-dorairaj11-11">&#91;11&#93;</a></sup><sup id="cite_ref-radcliffe12_12-6" class="reference"><a href="#cite_note-radcliffe12-12">&#91;12&#93;</a></sup> 
</p><p>However, there have been recent studies investigating the use of KDB in unique clinical scenarios including CACG, uveitis, and severe refractory glaucoma. A retrospective analysis of 42 eyes with CACG undergoing phaco plus KDB showed IOP reduction of 12.3 mmHg (p&lt;0.0001) as well as a reduction of IOP-lowering medications by 2.2 (p&lt;0.0001) at a 12 month follow up. Furthermore, 92.9% of eyes achieved IOP ≤18 mmHg, 100% achieved IOP reduction of ≥20%, 95.2% required ≥1 fewer medications for IOP control, and 85.7% (36/42) were medication-free.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">&#91;27&#93;</a></sup> In a small retrospective study of 16 uveitic eyes undergoing KDB either with or without phaco, Miller et al. showed 10 eyes (62.5%) maintained an IOP at or below their goal through their most recent follow-up visit (mean follow-up time of 9.6±5.6 months) and the mean number of glaucoma medications was significantly reduced by 1.5±1.4 medications (P=0.004).<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup> Finally, a retrospective analysis of 53 eyes with severe or refractory glaucoma demonstrated an IOP reduction of &gt;20% in 57.7% of eyes at 6 months. Furthermore, 63.5% and 92.3% of eyes achieved an IOP≤14 and ≤18 mm Hg, respectively, and the mean number of glaucoma medications was reduced by 1.2±1.3 (36.6%) compared with baseline (P&lt;0.001).<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup> 
</p>
<h1><span class="mw-headline" id="Conclusions">Conclusions</span></h1>
<p>KDB goniotomy is a safe and effective option for managing glaucoma in appropriate patients. Compared to other goniotomy/trabeculectomy procedures, it results in less surrounding tissue damage and a more complete removal of TM.<sup id="cite_ref-seibold13_13-5" class="reference"><a href="#cite_note-seibold13-13">&#91;13&#93;</a></sup><sup id="cite_ref-sooHoo14_14-4" class="reference"><a href="#cite_note-sooHoo14-14">&#91;14&#93;</a></sup> Clinical studies have demonstrated the efficacy of KDB goniotomy both with and without phacoemulsification for reduction of both IOP and medication dependence. However, given the relative novelty of this blade, most studies are limited to 12 month follow up. When compared against other MIGS devices such as the iStent, KDB produced equal, if not improved IOP lowering. Longer term follow-up and future prospective studies are needed to better elucidate the clinical outcomes of this device as well as determining the best candidates for the procedure.  
</p>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-tham1-1"><span class="mw-cite-backlink"><a href="#cite_ref-tham1_1-0">↑</a></span> <span class="reference-text">Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081-90. </span>
</li>
<li id="cite_note-grant2-2"><span class="mw-cite-backlink"><a href="#cite_ref-grant2_2-0">↑</a></span> <span class="reference-text">Grant WM. Clinical measurements of aqueous outflow. AMA Arch Ophthalmol. 1951;46(2):113-31.</span>
</li>
<li id="cite_note-tamm3-3"><span class="mw-cite-backlink"><a href="#cite_ref-tamm3_3-0">↑</a></span> <span class="reference-text">Tamm ER. The trabecular meshwork outflow pathways: Structural and functional aspects.&#160;Exp Eye Res.&#160;2009;88:648–55. </span>
</li>
<li id="cite_note-chang4-4"><span class="mw-cite-backlink"><a href="#cite_ref-chang4_4-0">↑</a></span> <span class="reference-text">Chang I, Caprioli J, Ou Y. Surgical Management of Pediatric Glaucoma. Dev Ophthalmol. 2017;59:165-178.</span>
</li>
<li id="cite_note-sieck5-5"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-sieck5_5-0">5.0</a></sup> <sup><a href="#cite_ref-sieck5_5-1">5.1</a></sup> <sup><a href="#cite_ref-sieck5_5-2">5.2</a></sup> <sup><a href="#cite_ref-sieck5_5-3">5.3</a></sup> <sup><a href="#cite_ref-sieck5_5-4">5.4</a></sup> <sup><a href="#cite_ref-sieck5_5-5">5.5</a></sup> <sup><a href="#cite_ref-sieck5_5-6">5.6</a></sup> <sup><a href="#cite_ref-sieck5_5-7">5.7</a></sup></span> <span class="reference-text">Sieck EG, et al. Outcomes of Kahook Dual Blade Goniotomy with and without Phacoemulsification Cataract Extraction. Ophthalmol Glaucoma. 2018 Jul-Aug;1(1):75-81.  </span>
</li>
<li id="cite_note-mansouri6-6"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-mansouri6_6-0">6.0</a></sup> <sup><a href="#cite_ref-mansouri6_6-1">6.1</a></sup> <sup><a href="#cite_ref-mansouri6_6-2">6.2</a></sup> <sup><a href="#cite_ref-mansouri6_6-3">6.3</a></sup></span> <span class="reference-text">Mansouri K, et al. Comparison of the Intraocular Pressure Lowering Efficacy Between a Novel Goniotomy Blade and a Trabecular Meshwork Device. Data presented as a poster at the XXXV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS); October 7-11, 2017, Lisbon, Portugal.</span>
</li>
<li id="cite_note-abdullah7-7"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-abdullah7_7-0">7.0</a></sup> <sup><a href="#cite_ref-abdullah7_7-1">7.1</a></sup> <sup><a href="#cite_ref-abdullah7_7-2">7.2</a></sup></span> <span class="reference-text">Abdullah S, Jasek MC, Radcliffe NM, et al. A novel dual blade device for goniotomy: initial clinical experience.&#160;Invest&#160;Ophthalmol Vis Sci.&#160;2016;57(12):6522.</span>
</li>
<li id="cite_note-greenwood8-8"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-greenwood8_8-0">8.0</a></sup> <sup><a href="#cite_ref-greenwood8_8-1">8.1</a></sup> <sup><a href="#cite_ref-greenwood8_8-2">8.2</a></sup> <sup><a href="#cite_ref-greenwood8_8-3">8.3</a></sup> <sup><a href="#cite_ref-greenwood8_8-4">8.4</a></sup> <sup><a href="#cite_ref-greenwood8_8-5">8.5</a></sup> <sup><a href="#cite_ref-greenwood8_8-6">8.6</a></sup></span> <span class="reference-text">Greenwood MD, Seibold LK, Radcliffe NM, et al. Goniotomy with a single-use dual blade: Short-term results. J Cataract Refract Surg. 2017;43(9):1197-1201.</span>
</li>
<li id="cite_note-francis9-9"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-francis9_9-0">9.0</a></sup> <sup><a href="#cite_ref-francis9_9-1">9.1</a></sup> <sup><a href="#cite_ref-francis9_9-2">9.2</a></sup> <sup><a href="#cite_ref-francis9_9-3">9.3</a></sup></span> <span class="reference-text">Francis BA, Minckler D, Dustin L, et al. Combined cataract extraction and trabeculotomy by the internal approach for coexisting cataract and open-angle glaucoma: initial results. J Cataract Refract Surg. 2008;34(7):1096-103.</span>
</li>
<li id="cite_note-mansouri10-10"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-mansouri10_10-0">10.0</a></sup> <sup><a href="#cite_ref-mansouri10_10-1">10.1</a></sup> <sup><a href="#cite_ref-mansouri10_10-2">10.2</a></sup> <sup><a href="#cite_ref-mansouri10_10-3">10.3</a></sup> <sup><a href="#cite_ref-mansouri10_10-4">10.4</a></sup> <sup><a href="#cite_ref-mansouri10_10-5">10.5</a></sup> <sup><a href="#cite_ref-mansouri10_10-6">10.6</a></sup></span> <span class="reference-text">Dorairaj SK, et al. 12-Month Outcomes of Goniotomy Performed Using the Kahook Dual Blade Combined with Cataract Surgery in Eyes with Medically Treated Glaucoma. Adv Ther. 2018 Sep;35(9):1460-1469.&#160; </span>
</li>
<li id="cite_note-dorairaj11-11"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-dorairaj11_11-0">11.0</a></sup> <sup><a href="#cite_ref-dorairaj11_11-1">11.1</a></sup> <sup><a href="#cite_ref-dorairaj11_11-2">11.2</a></sup> <sup><a href="#cite_ref-dorairaj11_11-3">11.3</a></sup> <sup><a href="#cite_ref-dorairaj11_11-4">11.4</a></sup> <sup><a href="#cite_ref-dorairaj11_11-5">11.5</a></sup> <sup><a href="#cite_ref-dorairaj11_11-6">11.6</a></sup></span> <span class="reference-text">Dorairaj SK, et al. A multicenter retrospective comparison of goniotomy versus trabecular bypass device implantation in glaucoma patients undergoing cataract extraction. Clin Ophthalmol. 2018;12:791-797.</span>
</li>
<li id="cite_note-radcliffe12-12"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-radcliffe12_12-0">12.0</a></sup> <sup><a href="#cite_ref-radcliffe12_12-1">12.1</a></sup> <sup><a href="#cite_ref-radcliffe12_12-2">12.2</a></sup> <sup><a href="#cite_ref-radcliffe12_12-3">12.3</a></sup> <sup><a href="#cite_ref-radcliffe12_12-4">12.4</a></sup> <sup><a href="#cite_ref-radcliffe12_12-5">12.5</a></sup> <sup><a href="#cite_ref-radcliffe12_12-6">12.6</a></sup></span> <span class="reference-text">Radcliffe, N, et al. A Novel Dual Blade Device for Goniotomy: Six-month Follow-up. Data presented as a poster at the American Glaucoma Society 27th Annual Meeting; March 2017; Coronado, California.</span>
</li>
<li id="cite_note-seibold13-13"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-seibold13_13-0">13.0</a></sup> <sup><a href="#cite_ref-seibold13_13-1">13.1</a></sup> <sup><a href="#cite_ref-seibold13_13-2">13.2</a></sup> <sup><a href="#cite_ref-seibold13_13-3">13.3</a></sup> <sup><a href="#cite_ref-seibold13_13-4">13.4</a></sup> <sup><a href="#cite_ref-seibold13_13-5">13.5</a></sup></span> <span class="reference-text">Seibold L. K., Soohoo J. R., Ammar D. A., Kahook M. Y. Preclinical investigation of ab interno trabeculectomy using a novel dual-blade device.&#160;American Journal of Ophthalmology.&#160;2013;155(3):524–529.e2.</span>
</li>
<li id="cite_note-sooHoo14-14"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-sooHoo14_14-0">14.0</a></sup> <sup><a href="#cite_ref-sooHoo14_14-1">14.1</a></sup> <sup><a href="#cite_ref-sooHoo14_14-2">14.2</a></sup> <sup><a href="#cite_ref-sooHoo14_14-3">14.3</a></sup> <sup><a href="#cite_ref-sooHoo14_14-4">14.4</a></sup></span> <span class="reference-text">SooHoo, J.R., L.K. Seibold, and M.Y. Kahook, Ab interno trabeculectomy in the adult patient. Middle East Afr J Ophthalmol. 2015;22(1):25-9.</span>
</li>
<li id="cite_note-allingham15-15"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-allingham15_15-0">15.0</a></sup> <sup><a href="#cite_ref-allingham15_15-1">15.1</a></sup></span> <span class="reference-text">Allingham RR, Damji KF, Freedman SF, Moroi SE, Rhee DJ, Shields MB. Shields textbook of glaucoma. Lippincott Williams &amp; Wilkins; 2012 Mar 28.</span>
</li>
<li id="cite_note-khouri16-16"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-khouri16_16-0">16.0</a></sup> <sup><a href="#cite_ref-khouri16_16-1">16.1</a></sup> <sup><a href="#cite_ref-khouri16_16-2">16.2</a></sup></span> <span class="reference-text">Khouri AS, Wong SH. Ab Interno Trabeculectomy With a Dual Blade: Surgical Technique for Childhood Glaucoma. J Glaucoma. 2017;26(8):749-751.</span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><a href="#cite_ref-17">↑</a></span> <span class="reference-text">King J, Lee D, Thomsen S, et al. Relationship between selective laser trabeculoplasty and excisional goniotomy outcomes in glaucomatous eyes. Can J Ophthalmol. 2021 Apr 8;S0008-4182(21)00089-2.</span>
</li>
<li id="cite_note-epstein17-18"><span class="mw-cite-backlink"><a href="#cite_ref-epstein17_18-0">↑</a></span> <span class="reference-text">Epstein, RS, Soohoo, JS, Pantcheva, MP, Seibold, LK, Kahook, MY. Optimal time for visualization with minimally invasive Glaucoma Surgeries: Before or After Phacoemulsification?  Data presented as a poster at the American Glaucoma Society 27th Annual Meeting; March 2017, Coronado, California.</span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><a href="#cite_ref-19">↑</a></span> <span class="reference-text">Xu H, Thomas MT, Lee D, et al. Response to netarsudil in goniotomy-treated eyes and goniotomy-naive eyes: a pilot study. Graefes Arch Clin Exp Ophthalmol. 2022.</span>
</li>
<li id="cite_note-grover18-20"><span class="mw-cite-backlink"><a href="#cite_ref-grover18_20-0">↑</a></span> <span class="reference-text">Grover DS, Godfrey DG, Smith O, Feuer WJ, Montes de oca I, Fellman RL. Gonioscopy-assisted transluminal trabeculotomy, ab interno trabeculotomy: technique report and preliminary results. Ophthalmology. 2014;121(4):855-61.</span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><a href="#cite_ref-21">↑</a></span> <span class="reference-text">Wakil SM, et al. Efficacy and safety of a single-use dual blade goniotomy: 18-month results. J Cataract Refract Surg. 2020 Oct;46(10):1408-1415.</span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><a href="#cite_ref-22">↑</a></span> <span class="reference-text">Falkenberry S, et al. Excisional goniotomy vs trabecular microbypass stent implantation: a prospective randomized clinical trial in eyes with mild to moderate open-angle glaucoma. J Cataract Refract Surg. 2020 Aug;46(8):1165-1171.</span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><a href="#cite_ref-23">↑</a></span> <span class="reference-text">ElMallah MK, Seibold LK, Kahook MY, Williamson BK, Singh IP, Dorairaj SK; KDB Goniotomy Study Group. 12-Month Retrospective Comparison of Kahook Dual Blade Excisional Goniotomy with Istent Trabecular Bypass Device Implantation in Glaucomatous Eyes at the Time of Cataract Surgery. Adv Ther. 2019 Sep;36(9):2515-2527.</span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><a href="#cite_ref-24">↑</a></span> <span class="reference-text">Hirabayashi MT, Lee D, King JT, Thomsen S, An JA. Comparison Of Surgical Outcomes Of 360° Circumferential Trabeculotomy Versus Sectoral Excisional Goniotomy With The Kahook Dual Blade At 6 Months. Clin Ophthalmol. 2019 Oct 15;13:2017-2024.</span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><a href="#cite_ref-25">↑</a></span> <span class="reference-text">Sieck EG, et al. Refractive outcomes among glaucoma patients undergoing phacoemulsification cataract extraction with and without Kahook Dual Blade goniotomy. Eye Vis (Lond). 2019 Sep 19;6:28.</span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><a href="#cite_ref-26">↑</a></span> <span class="reference-text">Bravetti GE, et al. Surgical outcomes of excisional goniotomy using the kahook dual blade in severe and refractory glaucoma: 12-month results. Eye (Lond) 2022. </span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><a href="#cite_ref-27">↑</a></span> <span class="reference-text">Dorairaj S, Tam MD, Balasubramani GK. Twelve-month outcomes of excisional goniotomy using the Kahook Dual Blade® in eyes with angle-closure glaucoma. Clin Ophthalmol. 2019 Sep 10;13:1779-1785.</span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><a href="#cite_ref-28">↑</a></span> <span class="reference-text">Miller VJ, Young CEC, SooHoo JR, Seibold LK, Kahook MY, Pecen PE, Palestine AG, Pantcheva MB. Efficacy of Goniotomy With Kahook Dual Blade in Patients With Uveitis-associated Ocular Hypertension. J Glaucoma. 2019 Aug;28(8):744-748.</span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><a href="#cite_ref-29">↑</a></span> <span class="reference-text">Salinas L, Chaudhary A, Berdahl JP, Lazcano-Gomez GS, Williamson BK, Dorairaj SK, Seibold LK, Smith S, Aref AA, Darlington JK, Jimenez-Roman J, Mahootchi A, Boucekine M, Mansouri K. Goniotomy Using the Kahook Dual Blade in Severe and Refractory Glaucoma: 6-Month Outcomes. J Glaucoma. 2018 Oct;27(10):849-855.</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035156
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.012 seconds
CPU time usage: 0.236 seconds
Real time usage: 1.648 seconds
Preprocessor visited node count: 966/1000000
Post‐expand include size: 5369/2097152 bytes
Template argument size: 1077/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 21180/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  533.353      1 Template:Article
100.00%  533.353      1 -total
 80.50%  429.330      4 Template:Infobox_section
 41.26%  220.079      6 Template:UserLookup
  6.00%   32.015      1 Template:Review_expired
  0.29%    1.527      1 Template:Get_active_contest
  0.19%    1.005      1 Template:Infobox_end
  0.16%    0.848      1 Template:Infobox_begin
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy&amp;oldid=87677">https://eyewiki.org/w/index.php?title=Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy&amp;oldid=87677</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzywejbc">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy&amp;oldid=87677" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Kahook_Dual_Blade:_Ab_Interno_Trabeculectomy&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on December 25, 2022, at 16:35.</div>
					<div>This page has been accessed 50,918 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.012},"limitreport":{"cputime":"0.236","walltime":"1.648","ppvisitednodes":{"value":966,"limit":1000000},"postexpandincludesize":{"value":5369,"limit":2097152},"templateargumentsize":{"value":1077,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":21180,"limit":5000000},"timingprofile":["100.00%  533.353      1 Template:Article","100.00%  533.353      1 -total"," 80.50%  429.330      4 Template:Infobox_section"," 41.26%  220.079      6 Template:UserLookup","  6.00%   32.015      1 Template:Review_expired","  0.29%    1.527      1 Template:Get_active_contest","  0.19%    1.005      1 Template:Infobox_end","  0.16%    0.848      1 Template:Infobox_begin"]},"cachereport":{"timestamp":"20230306035156","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":2396});});</script></body>
</html>